| Literature DB >> 27601851 |
Khadidja Dehimi1, Antonio Speciale2, Antonina Saija2, Saliha Dahamna1, Roberto Raciti2, Francesco Cimino2, Mariateresa Cristani2.
Abstract
BACKGROUND: Thymelaea microphylla Coss. et Dur. (Thymelaeaceae) (TM) is a rare medicinal plant endemic to Algeria. Leaves decoction is used in folk medicine for anticancer, anti-inflammatory, and antidiabetic properties.Entities:
Keywords: Cyclooxygenase-2; Thymelaea microphylla; inflammation; medicinal plant; oxidative stress; radical scavenger activity; tumor necrosis factor-α
Year: 2016 PMID: 27601851 PMCID: PMC4989796 DOI: 10.4103/0973-1296.186345
Source DB: PubMed Journal: Pharmacogn Mag ISSN: 0973-1296 Impact factor: 1.085
Content of total flavonoids and flavonols, and of gallic acid equivalents (as calculated in the Folin assay) determined in different TM extracts. Results are expressed as mean±S.D. of three determinations
Antioxidant activity/free radical scavenger of T. microphylla extracts measured by means of different in vitro tests. Results are expressed as: mean±SD of 3 experiments for ORAC values; 50% scavenging concentration (SC50) and 95% confidence limits (CL) in the DPPH and ABTS assays; 50% mean inhibition concentration (IC50) and 95% confidence limits (CL) in the SOD, protein denaturation and BCB assay. §TE: Trolox equivalents
Figure 1Cell viability, evaluated in the trypan blue assay, of human blood mononuclear cells exposed for 24 h to three doses of Thymelaea microphylla extracts. Cultures treated with vehicle alone were used as controls. Data represent percentage of viable cells (mean percentage) calculated from the number of viable cells in treated samples versus control/that was considered as 100%). Each point represents mean ± standard deviation of three experiments. *P < 0.05 versus vehicle treated cells
Figure 2Effect of Thymelaea microphylla acetone extract on release of (a) thromboxane B2 (in comparison with that of indomethacin, Indo) and of (b) prostaglandin E2 (in comparison with that of nimesulide, NIM) in human whole blood. Data are expressed as mean ± standard deviation of three independent experiments
Figure 3Cell viability in human umbilical vein endothelial cells pretreated with Thymelaea microphylla acetone extract (20–40 μg/ml) for 24 h and then exposed for 2 h to tumor necrosis factor-α (20 ng/ml). Cultures treated with the vehicle alone (dimethyl sulfoxide 0.1%) were used as controls. Data represent percentage of viable cells (mean percentage) calculated from the number of viable cells in treated samples versus control untreated and unexposed. *P < 0.05 versus respective tumor necrosis factor-α 0 ng/ml; §P < 0.05 versus vehicle exposed to tumor necrosis factor-α 20 ng/ml
Figure 4Effect of Thymelaea microphylla acetone extract on tumor necrosis factor-α induced mRNA expression of the adhesion molecule E-selectin, in human umbilical vein endothelial cells. Cells were pretreated with Thymelaea microphylla extract (20–40 μg/ml) for 24 h and then exposed for 2 h to tumor necrosis factor-α (20 ng/ml). Cultures treated with the vehicle alone (dimethyl sulfoxide 0.1%) were used as controls. Values are expressed as 2−ΔΔCt normalized to control and reported as mean ± standard deviation of three experiments. *P < 0.05 versus respective tumor necrosis factor-α 0 ng/ml; §P < 0.05 versus vehicle exposed to tumor necrosis factor-α 20 ng/ml
Figure 5Leukocyte adhesion to human umbilical vein endothelial cells pretreated with Thymelaea microphylla acetone extract (20–40 μg/ml) for 24 h and then exposed to tumor necrosis factor-α (20 ng/ml) for 2 h. A flask containing the co-culture and not exposed to tumor necrosis factor-α was used as control. Increase in leukocyte adhesion upon stimulation of human umbilical vein endothelial cells with tumor necrosis factor-α was calculated in relation to the basal adhesion of leukocytes to nonstimulated human umbilical vein endothelial cells (that was set to 1). Data are reported as mean ± standard deviation of three experiments. *P < 0.05 versus respective tumor necrosis factor-α 0 ng/ml; §P < 0.05 versus vehicle exposed to tumor necrosis factor-α 20 ng/ml
Changes in intracellular GSH levels in HUVECs pretreated for 24 h with T. microphylla acetone extract (20-40 μg/ml) and then for 2 h with TNF-α (20 μg/ml). Cultures treated with the vehicle alone (DMSO 0.1%) were used as controls. Data are expressed as mean±SD of the three independent experiments. °P<0.05 vs respective TNF-α 0 ng/ml; *P<0.05 vs vehicle exposed to TNF-α 20 ng/ml